---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-056340"
form_type: "8-K"
ticker: "FZMD"
cik: "0000319016"
company_name: "Fuse Medical, Inc."
filed_at: "2021-11-12T23:59:59+00:00"
generated_at: "2026-06-28T09:33:27.324500+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Fuse Medical obtains waiver of EBITDA default; loan limit cut to $2.55M, term extended to Feb 2022

## Summary
- Lender waived default for failing to meet $600K minimum EBITDA for trailing twelve months ended Sep 30, 2021.
- Aggregate loan limit reduced to $2,550,000 from prior level.
- Termination date extended to February 4, 2022; interest rate Prime + 1.00%.
- President/Chairman Mark Brooks’ annual salary capped at $550,000 as part of amendment.
- Company and guarantors released all claims against lender.

## SEC filing metadata
- accession: 0001564590-21-056340
- form_type: 8-K
- ticker: FZMD
- cik: 0000319016
- company_name: Fuse Medical, Inc.
- filed_at: 2021-11-12T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/319016/000156459021056340/0001564590-21-056340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/319016/000156459021056340/fzmd-8k_20211110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-056340
- JSON: https://secwatch.observer/filing/0001564590-21-056340.json
- Plain text: https://secwatch.observer/filing/0001564590-21-056340.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.